The Foundry Announces Successful First-In-Human Procedure In Study Of Innovative Transcatheter Mitral Valve Repair Technology
Share this article Share this article MENLO PARK, Calif., Jan. 11, 2021 /PRNewswire/ -- The Foundry today announced the successful completion of the first-in-human procedure with the Half Moon Medical transcatheter mitral repair technology (TMVr) at Oregon Health and Science University (OHSU) as part of an FDA-approved early feasibility study. The first patient treated has been discharged from the hospital and is recovering as expected. The investigational Half Moon mitral valve repair device, developed through a unique partnership between Medtronic (NYSE:MDT) and The Foundry, is designed to ...
Source: prnewswire.com